Global Population Statistics on Hyperbaric Oxygen Therapy Users in 2025: What We Know Now

Hyperbaric oxygen therapy (HBOT) is a medical treatment where people breathe pure oxygen in a pressurized chamber. This extra pressure lets more oxygen reach tissues, so the body can heal faster and fight infection better. Doctors use HBOT for problems like chronic wounds, radiation injuries, and decompression sickness in divers.

By 2025, we finally have enough global data to talk about Global population statistics on hyperbaric oxygen therapy users in 2025 with some confidence. Recent estimates suggest that more than 2 million people receive HBOT each year worldwide, and that number keeps climbing. There are now over 2,000 chambers in use across hospitals, wound centers, and private clinics, which shows how far HBOT has spread.

This article will walk through what those numbers really mean. We will look at how many people use HBOT, where they live, and which regions are growing the fastest. We will also review the main medical reasons people receive HBOT, from diabetic foot ulcers to complex post-surgical wounds.

As we move through the data, we will connect statistics with real-world trends, such as aging populations and rising rates of diabetes and cancer. These trends help explain why demand for HBOT is growing in North America, Europe, and especially across Asia Pacific. By the end, we will have a clear picture of how large the HBOT user population is in 2025, why it is expanding, and what that might mean for patients, clinicians, and health systems over the next decade.

I. What Is Hyperbaric Oxygen Therapy?

1.1 Simple explanation of how HBOT works and who it helps

In hyperbaric oxygen therapy (HBOT), a person lies or sits in a sealed chamber and breathes almost pure oxygen while the air pressure in the chamber is raised above normal room pressure. The session usually lasts from 60 to 120 minutes, and most treatment plans involve several sessions over days or weeks.

The higher pressure helps the lungs take in much more oxygen than they can at normal pressure. That extra oxygen then dissolves into the blood and reaches tissues that are damaged or lacking blood flow. In simple terms, HBOT:

• Brings more oxygen to areas that are slow to heal
• Helps the body fight infection
• Supports new blood vessel growth and tissue repair

Major centers such as the Mayo Clinic and Cleveland Clinic describe HBOT as a standard option for several serious problems. Common approved medical uses include:

• Diabetic foot ulcers and other chronic wounds
• Radiation injuries to tissue after cancer treatment
• Carbon monoxide poisoning
• Serious infections, such as certain bone or soft tissue infections

Some people also receive HBOT for off-label reasons, such as sports recovery, post-concussion symptoms, or other brain injuries. Private centers and wellness clinics often use modern hyperbaric oxygen chambers for these purposes. These off-label uses increase the total number of HBOT users worldwide, but they are much harder to track in official statistics.

Current estimates suggest that more than 2 million people receive HBOT each year across the globe, and that figure keeps rising as more clinics open and more physicians accept the therapy.

1.2 Why tracking HBOT users matters for public health in 2025

Knowing how many people use HBOT, and where they are, helps us understand wider health trends. HBOT use often follows the rise of chronic conditions and complex treatments:

• More diabetes means more chronic foot ulcers and infections
• Larger aging populations means more frail patients with slow-healing wounds
• High rates of major surgery create demand for support in difficult recoveries
• Growth in cancer care means more patients living with radiation damage

Each of these groups can feed into HBOT demand. That is one reason recent market analyses project that the global HBOT devices market will grow from about 3.8 billion USD in 2025 to over 6 billion USD by 2035, with forecasts such as Future Market Insights pointing to steady long term expansion. This growth in devices often mirrors growth in actual users.

Tracking how many people receive HBOT supports good planning. Hospitals and wound centers can decide:

• How many chambers they need
• How many trained staff to hire
• What kind of equipment, protocols, and training they should invest in

Public health agencies and health systems also gain a clearer view of how HBOT fits into broader care strategies, from advanced wound care to complex oncology support. When we look at global population statistics on hyperbaric oxygen therapy users in 2025, we are not just counting treatments. We are measuring how prepared our health systems are to support patients who need intensive healing support today and in the next decade.

II. How Many People Use Hyperbaric Oxygen Therapy Worldwide in 2025?

When we talk about global population statistics on hyperbaric oxygen therapy users in 2025, we have to balance two things: a clear sense of scale and honest limits on the data. There is no single global counter for HBOT, but we now have enough research and market data to describe the big picture with reasonable confidence.

Most recent estimates suggest that more than 2 million people worldwide receive HBOT in a typical year. This aligns with market reports that value the hyperbaric oxygen therapy market at roughly 4 billion USD in 2025 and project continued growth, as described in sources such as the hyperbaric oxygen therapy market overview by Precedence Research.

2.1 Estimated number of HBOT users and treatment sessions per year

When we say "HBOT users," we mean unique patients per year, not single visits. Almost every HBOT patient follows a treatment plan made up of many sessions.

Most medical protocols call for:

• About 20 to 40 sessions for chronic wounds, radiation injuries, and many other approved conditions
• Sometimes 60 sessions or more for complex or long-standing problems

If we take a simple example, suppose 2 million patients receive HBOT in 2025:

• At an average of 30 sessions each, that equals 60 million sessions
• At an average of 40 sessions each, that equals 80 million sessions

So, a "few million users" can translate into tens of millions of individual HBOT treatments every year. This also helps explain why the devices market is growing, as shown in forecasts like the hyperbaric oxygen therapy devices market report from Future Market Insights.

These user counts are estimates, not direct headcounts. Analysts combine:

• Sales data for HBOT chambers and accessories
• Activity reports from hospitals and wound clinics
• Insurance and billing claims where HBOT has its own codes

Because there is no single global registry of HBOT users, we work with ranges that fit both the financial data and clinical activity reports.

2.2 Why exact global HBOT numbers are hard to measure

Even though we want a simple global total, several factors make exact counts impossible today.

First, many countries do not track HBOT use in a national database. Some health systems only record HBOT as part of a general hospital stay, so the treatment does not appear as a separate item in public statistics.

Second, a large share of HBOT is delivered in private clinics. These centers often treat both approved and off-label indications. Their internal numbers may be accurate, but they are rarely shared in a way that feeds into national or global summaries.

Third, off-label and wellness uses add another layer of uncertainty. Athletes, people with post-concussion symptoms, and clients at wellness centers may receive dozens of sessions each year. Many of these treatments are paid out of pocket and never pass through insurance databases.

All of this creates gaps in our knowledge. Even with those gaps, the direction is clear. Market reports, chamber sales, and clinic expansion all point the same way: HBOT use is rising in most regions, with strong growth in North America and Asia Pacific in particular.

By being open about these limits, we build a more honest picture. We can say with confidence that millions of people receive HBOT worldwide in 2025 and that the number is growing, while also being transparent that no source can provide a precise global headcount.

III. Regional Breakdown: Where Are Most Hyperbaric Oxygen Therapy Users in 2025?

When we look at global population statistics on hyperbaric oxygen therapy users in 2025, clear regional patterns appear. North America and Europe host most HBOT users today, while Asia Pacific shows the fastest growth in new patients and new chambers. Latin America, the Middle East, and Africa still account for a smaller share, but demand is climbing as access improves.

Differences in insurance coverage, hospital capacity, private investment, and disease patterns all shape where HBOT is most common. Market reports that segment HBOT use by region, such as the analysis from Fortune Business Insights, point to the same picture: mature markets in North America and Europe, acceleration in Asia Pacific, and gradual expansion elsewhere.

3.1 North America: The largest share of HBOT users and strong insurance support

North America, led by the United States, likely holds the single largest share of HBOT users in 2025. Several forces support this position:

• A high number of hospital-based HBOT units
• Many dedicated wound care and outpatient centers
• Strong use of HBOT billing codes in Medicare, Medicaid, and private insurance

Insurers in the United States and Canada often cover HBOT for approved conditions such as:

• Diabetic foot ulcers
• Chronic non-healing wounds
• Radiation tissue injuries after cancer treatment
• Certain infections and acute emergencies

Because these indications are common in aging and diabetic populations, they generate a large and steady flow of patients into HBOT programs. Diabetic foot ulcers alone can require 20 to 40 sessions per person, which increases both user counts and total sessions.

At the same time, an expanding network of outpatient and wellness centers adds many users for off-label reasons, from sports recovery to post-concussion symptoms. These patients may pay out of pocket, guided in part by resources that compare hyperbaric oxygen therapy costs and benefits such as this HBOT cost and risk overview. Their activity often falls outside national statistics, so the true number of HBOT users in North America is likely higher than formal reports suggest.

3.2 Europe: Established hospital programs and research-driven growth

Europe holds a large share of HBOT users as well, but the pattern looks different from North America. Many countries, including Germany, the United Kingdom, France, Italy, and the Netherlands, have long-standing HBOT programs rooted inside hospitals and academic centers.

Treatment often follows strict clinical guidelines and national reimbursement rules. These rules may limit off-label or wellness use, but they help create:

• Clear patient selection criteria
• Standardized treatment protocols
• Strong data for clinical research

As a result, Europe contributes a significant share of the global evidence base on HBOT, even if total user numbers grow at a moderate pace. Aging populations, high rates of diabetes, and complex wound care in vascular and cancer centers support steady demand.

Radiation injuries, chronic wounds after surgery, and diabetic foot ulcers remain leading reasons for HBOT referrals. Because much of this care runs through public or social insurance systems, access can be broad for approved indications, even when off-label use is limited.

3.3 Asia-Pacific: Fastest growth in HBOT users driven by diabetes and medical tourism

Asia Pacific is the fastest-growing region for HBOT in 2025. Market analyses such as those from Precedence Research and other device forecasts highlight strong growth rates for HBOT systems in this region.

Countries like China, India, Japan, South Korea, and several Southeast Asian nations are expanding hospital infrastructure and advanced wound care services. Several trends support rapid growth in HBOT use:

• Very high and rising rates of type 2 diabetes, with more diabetic foot ulcers
• Rapid hospital construction and adoption of advanced therapies
• Dense urban populations, which make multi-place HBOT centers more efficient
• Medical tourism, where patients travel for lower-cost or bundled HBOT packages

In major cities, new private clinics and large multi-place chambers are opening in tertiary hospitals and specialized centers. As more clinicians gain experience with HBOT and middle-income groups expand, access widens each year.

User counts in Asia Pacific still trail North America and Europe today, but the growth rate is higher. Many analysts expect this region to contribute a growing share of global population statistics on hyperbaric oxygen therapy users in 2025 and beyond.

3.4 Latin America, Middle East, and Africa: Smaller numbers but rising demand

Latin America, the Middle East, and Africa start from a smaller base of HBOT installations, but user numbers are rising. Access tends to cluster in large cities, where private hospitals and academic centers install modern chambers.

In these regions, HBOT use often centers on:

• Diving injuries and decompression sickness in coastal or offshore areas
• Burns and trauma in major referral hospitals
• Selected chronic wound and diabetic foot ulcer cases in urban wound centers

Rural areas usually have little or no access to HBOT, since chambers are expensive and need trained staff, stable power, and strong safety systems. This urban concentration limits total user numbers today.

Growth is still meaningful, helped by:

• Rising awareness among surgeons and wound care teams
• Expansion of private insurance and employer-based coverage in some cities
• International training links with established centers in North America and Europe

Better training, targeted funding, and strong referral pathways could significantly increase HBOT users in these regions over the next decade. As more countries invest in advanced wound care, trauma services, and burn units, HBOT will likely move from niche service to a more routine option for complex cases.

IV. What Conditions Drive HBOT Use in 2025 and How Does This Shape Global Numbers?

We connect global population statistics on hyperbaric oxygen therapy users in 2025 to the conditions that prompt most treatments. Recent estimates place annual users at about 2.5 million worldwide, rising as access improves in hospitals and private centers. Chronic wounds and diabetes drive about 40–45% of cases, while radiation injuries, infections, and emergencies add another 30%. Off-label uses for brain injuries, autism, and sports recovery contribute an extra 25–30%, often in settings that do not report into national databases. This mix of approved and off-label use explains both the growth in HBOT and the difficulty of getting a precise global headcount, which market analyses such as Grand View Research reflect in their long-term growth projections.

4.1 Chronic wounds and diabetes as the main drivers of HBOT demand

Chronic wounds are injuries that fail to heal in a reasonable time, often longer than 30 days. They usually stem from poor blood flow, pressure on the skin, or underlying conditions that slow repair. Diabetic foot ulcers are one of the most common types. High blood sugar damages nerves and blood vessels, so a small cut on the foot can turn into a deep, infected sore that resists standard care.

These wounds are hard to treat because the root problem is reduced circulation and damaged tissue, not just surface infection. Even good wound care may not be enough if oxygen levels in the tissue stay low. HBOT increases oxygen in the blood and helps it reach the wound, which supports tissue repair and helps antibiotics work better.

As global diabetes cases pass 500 million adults in 2025, foot ulcers and related complications rise in parallel. We see that link clearly in HBOT statistics, where diabetic foot ulcers and other chronic wounds account for the largest share of treated conditions. Many HBOT centers devote most of their schedule to these patients, with typical plans of 30 to 40 sessions per person. That means even a modest number of wound patients creates a very high treatment volume. A single busy center can run thousands of wound-related sessions each year. For a broader overview of where HBOT is used across wound and diabetic complications, the article on hyperbaric oxygen therapy applications gives added clinical context.

4.2 Radiation injuries, serious infections, and emergency uses

Radiation therapy can save lives, but it can also damage healthy tissue around a tumor. Months or years after treatment, some patients develop radiation tissue injuries, such as soft tissue radionecrosis or osteoradionecrosis of the jaw. In many countries, HBOT is written into guidelines as part of standard care for these problems. Extra oxygen helps restore damaged blood vessels, reduce chronic inflammation, and support gradual healing.

Serious infections, especially in bone (chronic osteomyelitis) or deep soft tissue, also appear regularly in HBOT statistics. Bacteria in poorly perfused areas are hard to treat with antibiotics alone. HBOT raises tissue oxygen levels, which boosts white blood cell function and improves antibiotic action. Carbon monoxide poisoning is a classic emergency indication. HBOT speeds removal of carbon monoxide from hemoglobin and helps limit brain and heart injury.

These cases are fewer than chronic wound and diabetes cases but they are tracked very clearly. Hospital billing and diagnosis codes capture most radiation, infection, and carbon monoxide cases that receive HBOT. They also cluster in regions with strong cancer services and more industrial exposure. Clinical resources from the Undersea and Hyperbaric Medical Society on radiation tissue damage describe how these indications fit into routine hospital practice, which feeds into more reliable global statistics.

4.3 Off-label and wellness uses that add to HBOT user counts

Off-label HBOT covers a wide group of conditions that do not appear on most official indication lists but attract strong interest from patients and private providers. Common examples include:

• Traumatic brain injury and post-concussion symptoms
• Stroke recovery and chronic neurological deficits
• Autism spectrum disorder
• General wellness, anti-aging, and sports recovery

In traumatic brain injury and stroke, HBOT may help by improving oxygen delivery to injured but not dead brain tissue. Some athletes use HBOT to speed recovery after intense training or injury, aiming for faster muscle repair and reduced soreness. Families of children with autism sometimes seek HBOT hoping to support brain function, though research findings remain mixed.

These users often receive HBOT in private clinics or wellness centers, not hospital-based units. Sessions are frequently paid out of pocket, sold in packages, and recorded in local systems that never reach national databases. As a result, many off-label users do not appear in formal counts, even when they add a large number of sessions in total.

This gap makes global population statistics on hyperbaric oxygen therapy users in 2025 harder to pin down. Official data mostly covers approved indications, especially chronic wounds, radiation injuries, infections, and emergencies. Off-label and wellness use sits on top of that base, adding perhaps a quarter or more to real user numbers but with poor visibility. Reviews of off-label HBOT in TBI and stroke highlight both the growing interest and the lack of unified reporting, which we must factor in when we interpret any global HBOT totals for 2025.

V. Key Trends Shaping Global HBOT Use in 2025

When we look at global population statistics on hyperbaric oxygen therapy users in 2025, a few clear trends stand out. HBOT is no longer a niche tool for diving injuries. It is becoming a routine part of wound care, oncology support, and even selected outpatient and wellness services across many regions.

5.1 Rising device market and clinic expansion worldwide

Analysts project that the HBOT devices market will grow from about 3.8 billion USD in 2025 to more than 6 billion USD by 2035, as outlined in forecasts such as the hyperbaric oxygen therapy devices market report from Future Market Insights. That kind of growth almost always reflects real patients, not just equipment sitting idle.

We see this in the steady rise of:

• Hospital-based hyperbaric units
• Integrated wound care centers
• Independent outpatient and wellness clinics

Hospitals and trauma centers often invest in large multi-place chambers. These units treat several patients at once, which works well for busy programs that handle emergencies, complex wounds, and radiation injuries. Multi-place systems demand more space, infrastructure, and staff, but they support higher throughput and more advanced monitoring.

Outpatient settings usually rely on single-place (monoplace) chambers. These are easier to install, simpler to staff, and fit better into wound care clinics or private practices. Growth in single-place systems has opened HBOT to smaller cities and private providers, who can now explore HBOT chamber options for clinics using solutions such as the Hyperbaric Oxygen Therapy Chambers for Sale from manufacturers like LANNX.

As chambers spread into more locations, annual patient counts rise. The expanding devices market is therefore tightly linked to the steady climb in global HBOT users recorded in 2025.

5.2 Insurance coverage, clinical guidelines, and policy changes

Insurance rules largely decide who reaches HBOT and how many sessions they receive. In countries where public health systems or private insurers cover HBOT for diabetic foot ulcers, radiation injuries, and approved emergencies, population use is higher and more stable. Detailed medical policies, such as the clinical guidance provided in Aetna's hyperbaric oxygen therapy coverage criteria, shape referral patterns and boost confidence among clinicians.

Where patients must pay in full, HBOT use tends to cluster in wealthier groups and in large urban centers. Clinics may still run full schedules, but user counts at the national level stay lower, even when the medical need is large.

Policy changes also shift global population statistics on hyperbaric oxygen therapy users in 2025. When a new indication is added to a national coverage list, such as certain radiation injuries or severe soft tissue infections, thousands of extra patients can become eligible almost overnight. Updated clinical guidelines that recommend HBOT earlier in the care pathway have a similar effect, moving the therapy from last resort to standard component of advanced care.

Looking ahead, we can expect future user numbers to track closely with how fast payers update coverage lists and how quickly guideline groups respond to new evidence.

5.3 Public awareness, research evidence, and safety standards

Growth in HBOT use also rests on awareness and trust. More physicians now recognize HBOT as part of modern wound and radiation care, helped by a growing research base and market reports such as the global HBOT market overview from The Business Research Company. Patients arrive at clinics better informed, often after reading about HBOT outcomes or hearing from others who completed a treatment course.

Clear safety protocols and trained staff reduce complication rates and reassure hospital leaders and regulators. Standardized checklists, regular chamber maintenance, and well defined emergency drills all help position HBOT as a reliable therapy, not a risky add-on. This is especially important as technology advances, with more compact systems and, in some regions, portable or home-use chambers used under medical supervision.

Better data collection will sharpen future statistics. As more centers track indications, outcomes, and adverse events in structured registries, health systems will gain a clearer picture of who uses HBOT, which conditions benefit most, and where access gaps remain. That kind of information will guide planning, support smarter investment in chambers and staff, and refine global estimates of HBOT users well beyond 2025.

VI. What These Global HBOT Statistics Mean for Patients, Providers, and Policy Makers

Global population statistics on hyperbaric oxygen therapy users in 2025 tell us much more than how many chambers are in service. These numbers hint at who gets access, which conditions receive priority, and where gaps in care still exist. When we read the data with that in mind, we can start to see what should change next for patients, providers, and health leaders.

6.1 Implications for patients who may benefit from HBOT

For patients, rising HBOT use usually signals more choice, not automatic better care. As more centers open, people with hard to heal wounds or radiation injuries are more likely to have a realistic option near home instead of traveling long distances or going without treatment.

Patients can protect themselves by taking a few clear steps:

• Ask about approved medical uses, such as diabetic foot ulcers, radiation tissue damage, or serious infections.
• Request a simple explanation of expected benefits, how many sessions are planned, and how progress will be tracked.
• Discuss risks and side effects, such as ear pressure, blood sugar changes, or rare oxygen toxicity, and how the team manages these.

We should also look for accredited centers with trained staff, clear protocols, and proper monitoring. Large summaries of HBOT data, such as the market and outcome trends reviewed in the hyperbaric oxygen therapy statistics overview, highlight how much results can vary by indication and setting. That is a reminder to ask direct questions and avoid clinics that promise cures for everything.

6.2 Implications for clinics, hospitals, and health systems

For providers, millions of HBOT users across the world in 2025 mean real planning pressure. Clinics and hospitals that see more chronic wounds, radiation injuries, and complex infections need to decide if they will:

• Invest in enough chambers for timely access.
• Train physicians, nurses, and technicians in hyperbaric medicine.
• Build simple patient education tools that explain the process and expectations.

Good infrastructure behind the scenes matters as much as the chamber itself. Health systems benefit from:

• Standard referral pathways from diabetes, oncology, and surgery services.
• Data collection on indications, outcomes, and complications.
• Strong safety practices for fire prevention, pressure changes, and emergency response.

Global trends and market data, such as those in the HBOT market forecast through 2034, can help leaders judge if they should add or expand HBOT programs. Comparing local wound and radiation case loads with these trends can show where underuse or overuse may exist.

6.3 Implications for policy makers and future HBOT planning

For policy makers, global HBOT statistics act like a dashboard. They point to regions where use is high but outcomes are unclear, and others where need is high but access is scarce. This can guide:

• Coverage rules for approved conditions, so cost does not block effective care.
• Targeted investments in centers in high diabetes or high cancer regions.
• Funding for trials that test HBOT in areas where evidence is still limited.

Better, more consistent reporting of HBOT cases and outcomes would help everyone. Health plans could refine coverage, clinics could benchmark performance, and patients could see more honest expectations. Clear, transparent statistics on global population statistics on hyperbaric oxygen therapy users in 2025, and in the years that follow, give us the foundation we need to plan HBOT services responsibly for the next decade.

VII. FAQ About Global HBOT Statistics in 2025

Conclusion